saplin

UTI Innovation Fund

UTI Innovation Fund (Direct, Growth): saplin Score 4.1/10 (Weak) among 126 Sectoral/Thematic funds. 3Y return 4.8% a year vs 14.7% category median, expense ratio 1.21%. Returns that trail most peers hold this fund back. NAV ₹11.69 on 11 Nov 2026.

Loading the full analysis…

Questions about UTI Innovation Fund

What is the expense ratio of UTI Innovation Fund?

The Direct plan's total expense ratio is 1.21% a year, against a median of 1.20% for sectoral/thematic funds. The Regular plan costs more because it pays a distributor's commission.

Who manages UTI Innovation Fund?

Nitin Jain (since 1 Oct 2024).

What are the top holdings of UTI Innovation Fund?

Eternal 9.83%, Info Edge (India) 8.99%, FSN E-Commerce Ventures 6.81%, Acutaas Chemicals 6.10%, Affle 3i 5.17% of the portfolio, as of 31 Oct 2026.

What returns has UTI Innovation Fund given?

1 year: -4.3% (category median 4.6%); 3 years: 4.8% a year (category median 14.7%). Past returns do not predict future ones.

How big is UTI Innovation Fund?

About ₹807 cr (AMFI's average for the latest quarter).

How does UTI Innovation Fund score?

4.1 out of 10 (Weak) on the saplin Score, which rates a fund against its own category on returns, risk, consistency, cost and its manager. See the methodology for how it is worked out.

More on UTI Innovation